Wird geladen …
Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Online Artikel Text |
Sprache: | English |
Veröffentlicht: |
Nature Publishing Group UK
2018
|
Schlagworte: | |
Online Zugang: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762690/ https://www.ncbi.nlm.nih.gov/pubmed/29321470 http://dx.doi.org/10.1038/s41467-017-02205-9 |